Clinical Benefit of Empiric High-Dose Levofloxacin Therapy for Adults With Community-onset Enterobacteriaceae Bacteremia

研究成果: Article同行評審

1 引文 斯高帕斯(Scopus)

指紋

深入研究「Clinical Benefit of Empiric High-Dose Levofloxacin Therapy for Adults With Community-onset Enterobacteriaceae Bacteremia」主題。共同形成了獨特的指紋。

Medicine & Life Sciences